| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 22.42B | 21.00B | 21.38B | 23.75B | 20.82B |
| Gross Profit | 4.87B | 4.60B | 4.65B | 4.69B | 3.57B |
| EBITDA | 1.66B | 1.93B | 1.95B | 2.01B | 1.64B |
| Net Income | 1.07B | 1.08B | 1.10B | 1.11B | 988.60M |
Balance Sheet | |||||
| Total Assets | 16.03B | 14.68B | 13.28B | 13.13B | 13.20B |
| Cash, Cash Equivalents and Short-Term Investments | 618.70M | 717.70M | 588.70M | 315.20M | 258.10M |
| Total Debt | 6.30B | 5.99B | 5.81B | 6.10B | 7.35B |
| Total Liabilities | 12.18B | 12.33B | 11.24B | 11.53B | 12.49B |
| Stockholders Equity | 2.61B | 2.35B | 2.04B | 1.60B | 705.70M |
Cash Flow | |||||
| Free Cash Flow | 1.09B | 1.15B | 1.45B | 1.21B | 684.60M |
| Operating Cash Flow | 1.21B | 1.28B | 1.60B | 1.34B | 784.60M |
| Investing Cash Flow | 70.20M | -659.20M | -229.60M | -164.50M | -2.77B |
| Financing Cash Flow | -1.18B | -686.90M | -1.10B | -1.10B | 832.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | $21.68B | 15.40 | 31.05% | 0.87% | 6.48% | 22.17% | |
71 Outperform | $31.95B | 14.65 | 15.16% | 1.46% | 7.44% | -4.57% | |
68 Neutral | $9.26B | 20.67 | 10.34% | ― | 14.26% | -15.49% | |
66 Neutral | $24.40B | 15.81 | 15.82% | 2.78% | -1.97% | 48.61% | |
65 Neutral | $16.18B | 15.38 | 43.02% | 1.81% | 6.09% | -3.84% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | $11.36B | 16.26 | 86.85% | ― | 5.24% | -16.05% |
On February 4, 2026, CDW reported its fourth quarter and full-year 2025 results, highlighting solid top-line growth despite ongoing economic and geopolitical uncertainty. Fourth-quarter 2025 net sales rose 6.3% year-on-year to $5.51 billion, with average daily sales up 4.6% and strength in software, notebooks and mobile devices, and services, while gross profit increased 8.6% to $1.25 billion and margin improved to 22.8% on higher contribution from netted-down revenue. Segment performance was mixed but generally positive, with corporate sales slightly lower, small business revenue surging 18.4%, public segment sales up 7.0% driven by double-digit growth in education and mid-single-digit gains in healthcare and government, and UK/Canada sales up 8.4%. Operating income for the quarter grew 5.4% to $431 million, while net income increased 5.8% to $280 million and diluted EPS rose to $2.14, supported by lower state taxes and disciplined capital management, even as selling and administrative expenses climbed on higher performance-based pay and coworker costs. For the full year 2025, CDW delivered 6.8% net sales growth to $22.42 billion and maintained strong cash generation that enabled both M&A activity and the return of approximately $982 million to shareholders via dividends and share repurchases; the board reinforced this shareholder-return strategy by declaring a quarterly cash dividend of $0.63 per share payable on March 10, 2026 to stockholders of record on February 25, 2026.
The most recent analyst rating on (CDW) stock is a Hold with a $132.00 price target. To see the full list of analyst forecasts on CDW stock, see the CDW Stock Forecast page.
On December 17, 2025, CDW LLC entered into a new five-year $2.88 billion senior unsecured credit facility, comprising a $634.5 million term loan and a $2.25 billion multi-currency revolving credit facility, to refinance existing debt, fund working capital, and support general corporate purposes. The agreement consolidates and replaces CDW’s prior term and revolving loan arrangements, introduces updated market terms and flexible incremental capacity of up to $1 billion, and maintains a maximum leverage covenant with provisions allowing temporary higher leverage following qualified acquisitions, collectively enhancing the company’s financial flexibility and access to liquidity. On December 19, 2025, CDW Corporation also renewed and extended compensation protection agreements for four named executive officers through January 1, 2029, modifying bonus-related severance calculations and reaffirming restrictive covenants such as non-competition, which signals continued focus on leadership retention and governance stability.
The most recent analyst rating on (CDW) stock is a Buy with a $177.00 price target. To see the full list of analyst forecasts on CDW stock, see the CDW Stock Forecast page.